CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Diamond Biofund Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Diamond Biofund Inc
Phone: +886 227031338p:+886 227031338 TAIPEI, 106  Taiwan Ticker: 69016901
Business Summary
Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023-----

Industries
SIC Code Description
6799 Investors, not elsewhere classified
6282 Investment advice

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board KongmingLu
Vice Chairman of the Board ZudeLi
Acting Chief Financial Officer, Finance Director YuantingWu 12/22/2023 12/1/2021
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 28 (As of 12/31/2023)
Outstanding Shares: 849,890,000 (As of 1/31/2024)
Shareholders: 6,891
Stock Exchange: TPE
Fax Number: +886 227031576


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024